Safety and efficacy data on the investigational subcutaneous formulation of ORENCIA in adults with moderate to severe rheumatoid arthritis to be presented at the American College of Rheumatology ...
August 2, 2011 — The US Food and Drug Administration (FDA) has approved a subcutaneous formulation of abatacept (Orencia, Bristol-Myers Squibb Co) for the treatment of adults with moderate-to-severe ...
Dec. 29, 2005 — The U.S. Food and Drug Administration (FDA) has approved abatacept injection for the treatment of moderately to severely active rheumatoid arthritis in adults who have had an ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Philip Day loved playing soccer so much that the 35-year-old software engineer founded a website -- FootballMatcher.com -- to help people connect for pickup games. The fun went on pause when Day ...
The approval of the prefilled syringe was based on dosing, efficacy, and safety data of SC abatacept in JIA among patients aged 2-17 years with inadequate response to at least one nonbiologic or ...
Share on Pinterest A new clinical trial found that abatacept, a drug used to treat rheumatoid arthritis, may also help to prevent the disease. filadendron/Getty Images A study has found that the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results